Who Is Dr. Hugh Sampson?
Dr. Hugh Sampson is an esteemed healthcare professional with a specialty in pediatric allergy and immunology. He is the Kurt Hirschhorn Professor of Pediatrics at the Icahn School of Medicine at Mount Sinai in New York City and the Director Emeritus of the Jaffe Food Allergy Institute at Mount Sinai. Dr. Sampson has received a variety of awards, including but not limited to the Brett Ratner Award for Outstanding Research in Pediatric Allergy/Immunology, as well as the International Award in Nutrition for Outstanding research in the area of milk allergy. Dr. Sampson earned his Doctorate of Medicine at SUNY Buffalo.
What Is His Specialty?
Dr. Sampson specializes in pediatric allergy and immunology. According to Mount Sinai, beyond food allergy, his research interests include “pathogenesis of food-induced anaphylaxis, characterization of allergenic food proteins and their processing by the immune system, genetics of food allergy, development of novel diagnostic tests, and mechanisms of immunotherapeutic strategies for treating food allergies including basic studies and clinical trials in oral, sublingual and epicutaneous immunotherapy and the potential use of biologics, such as anti-IgE and anti-cytokine monoclonal antibodies.”
What Work Is He Currently Doing?
Dr. Sampson is currently a professor at the Icahn School of Medicine at Mount Sinai, as well as Director Emeritus of the Jaffe Food Allergy Institute. He is leading a pilot study on Exposure to Vaginal Microbiome in C-section Infants at High-risk for Allergies. The conditions for this trial are allergic diseases and asthma, and the treatments are C-section – Vaginal seeding, C-section – Placebo Seeding, and standard care.
Social Media Presence
From his contributions and studies, Dr. Sampson has amassed 585 mentions on social media.
What Is His Research Background?
Dr. Sampson has co-authored a total of 908 publications throughout the span of his tenure so far. These works have been mentioned in 64,600 citations. He has participated in fifteen clinical trials. The top conditions for those trials have been food hypersensitivity, and the top interventions for the trials were oral mucosal immunoprophylaxis (OMIP) and placebo.
H1 commends Dr. Sampson for his hard work in pediatric allergy and immunology and the impact that his research has had in the medical field. We eagerly await additional updates from his work, and are grateful for his positive impact in the allergy and immunology space. See how HCP Universe can provide insights like these on millions of similar key opinion leaders.
And check out our case study A Global Medical Affairs Team Finds Opportunity with H1 to see how others have had success expanding their KOL lists.